Acute Bacterial Skin and Skin Structure Infections Market Synopsis

Acute Bacterial Skin and Skin Structure Infections Market Size Was Valued at USD 3631.8 Million in 2023, and is Projected to Reach USD 6032.5 Million by 2032, Growing at a CAGR of 5.8% From 2024-2032.

ABSSSI means Acute Bacterial Skin and Skin Structure Infection, that is, bacterial infection that develops on the skin and in the immediate subcutaneous tissue. These are cellulitis, wound infection, major abscesses and necrotising fasciitis which is a serious skin infection. ABSSSI is mostly due to gram-positive pathogens and is most frequently associated with Staphylococcus aureus and the Streptococci group especially those generators of methicillin –resistant Staphylococcus aureus (MRSA). These infections may require admission and may be handled by specialists when complicated. Therefore, antibiotic therapies and other combination therapies of ABSSSI treatments is part of the market patient treatments.

• The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market has grown a lot over the past few years. This is because more people are getting bacterial infections, especially MRSA infections that are immune to medicines. Healthcare systems around the world are having a harder time right now because antibiotic resistance is making infections worse. To deal with these infections, everyone is working on new treatments and drugs. This is why the market is growing: older people are more likely to get serious skin diseases because they have diabetes and their immune systems are weaker. More people are also looking for new options because they know how important it is to find and treat ABSSSI early.
• The market is expected to grow even more because of faster new antibiotics being made and the use of combination treatments to fight resistant strains. Also, around the world, governments and healthcare groups are being forced to change people's minds about how to treat bacterial illness so that more Medicare problems and hospital stays can be avoided. Outpatient care has also become very popular because of rising costs for hospitals and a growing desire to shorten the length of hospital stays.

Acute Bacterial Skin and Skin Structure Infections Market Trend Analysis

Focus on Novel Antibiotics and Combination Therapies

• Depending on the above factors, the following trends can be projected to influence growth of the ABSSSI market: • One of the key trends is the innovation of new antibiotics and combination therapies for drug-resistant bacteria. With an increased incidence of antibiotic-resistant bacteria such as MRSA, companies continue to research and launch new molecules and methods. Specifically, there is a shift towards those drugs the application of which can contribute to a decrease in the patients’ stay in a hospital or can be used in outpatient settings. The daily applications with a shorter treatment period and fewer administrations and simple dosing have been significantly more acceptable to both the patient and the healthcare as it boosts patient compliances and global health care costs.

Rising Demand for Outpatient Treatments

• Another interesting fact, which is a potential opportunity in the context of the ABSSSI market, is the constantly escalating outpatient service requirement. The pressure on health care organizations to reduce costs and enhance patient satisfaction create an increasing demand for applications that can heal patients besides the hospital. New antibiotics with precise effectiveness, comfortable format of administration, and suitability to be used at home are increasing in preference. It is especially important for patient care in developed markets that experience higher healthcare costs and where outpatient treatments are taking over. Congratulations to Companies that have concentrated on creating beneficial outpatient treatments that are easy for use thereby enhancing patients’ relaxation are strategically placed to benefit from this development, much of this in parts of the world, where cost containment of healthcare services is an attributing factor.

Acute Bacterial Skin and Skin Structure Infections Market Segment Analysis:

Acute Bacterial Skin and Skin Structure Infections Market is segmented on the basis of type, route of administration and end user.

By Type, Hospital-acquired ABSSSI segment is expected to dominate the market during the forecast period

• The Hospital-acquired ABSSSI segment should continue to have the largest share for the market throughout the forecast period because of growing incidence of bacteria associated skin infections within hospital patients populating impaired immune systems, surgical patients, and those utilizing catheters or other invasive medical devices. Hai is very risky because such infections are caused by antibiotic-resistant bacteria leading to complications during treatment. Other factors contributing to the increased occurrence of these infections include increased early invasive procedures, prolonged hospitalization as well as increased elderly population. Therefore, the need for suitable systems and encapsulated antibiotics that can target hospital-acquired ABSSSI is increasing in this segment, due to high morbidity, mortality and overall healthcare costs for the patients afflicted with these infections.

By Route of Administration, Oral segment expected to held the largest share

• The Oral segment is anticipated to have the largest demand in the ABSSSI market based on the route of administration due to the increasing global trend for non-invasive, convenient, and cost-effective treatment. They are also preferred in outpatient practice because of ease of administration, improved patient compliance and decreased requirement of hospital visits or admission or prolonged hospital stay. This segment’s growth is also backed up by oral formulations that have improved to give results like that of intravenous therapies including for cases with major bacterial infections. Also, healthcare systems prefer oral antibiotics because, in general, they have a lower cost of treatment and enable control of processes outside the healthcare organization, which further contributes to the growth of the market.

Acute Bacterial Skin and Skin Structure Infections Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• During 2023, North America emerged as the largest market for ABSSSI, owing to a well-developed healthcare system and increased smartphones usage rate, bacterial infections incidence, and demand for antibiotic stewardship. It had a significant market share and the U.S. and comprising large pharma companies, strong research activities coupled with large patient pool. Preliminary data suggests that North America alone accounted for 40% or more of the total population seeking ABSSSI treatments in 2023. The region is most likely by increased uptake of new technologies in the treatment of diseases, sound governmental policy support on comprehensive care research, and policy directives that seek to address antibiotic resistant infections.

Active Key Players in the Acute Bacterial Skin and Skin Structure Infections Market

• Achaogen, Inc. (USA)
• Allergan PLC (Ireland)
• Basilea Pharmaceutica Ltd. (Switzerland)
• Cumberland Pharmaceuticals Inc. (USA)
• GlaxoSmithKline PLC (UK)
• Melinta Therapeutics (USA)
• Merck & Co., Inc. (USA)
• Mylan N.V. (USA)
• Paratek Pharmaceuticals, Inc. (USA)
• Pfizer Inc. (USA)
• Sandoz (Switzerland)
• Shionogi & Co., Ltd. (Japan)
• The Medicines Company (USA)
• Theravance Biopharma, Inc. (USA)
• Wockhardt Ltd. (India), Other key Players.

Key Industry Developments in the Acute Bacterial Skin and Skin Structure Infections Market:

• In May 2022, in order to continue promoting and distributing SIVEXTRO (tedizolid phosphate) in the US, Nabriva Therapeutics PLC has finalized a deal to extend its exclusive cooperation with Merck & Co. Inc. subsidiaries. Acute bacterial skin and skin structure infections (ABSSSI) are treated with SIVEXTRO, an antibiotic belonging to the oxazolidinone class. With this extension, the partnership will continue until December 2026.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Acute Bacterial Skin And Skin Structure Infections Market by Type
 4.1 Acute Bacterial Skin And Skin Structure Infections Market Snapshot and Growth Engine
 4.2 Acute Bacterial Skin And Skin Structure Infections Market Overview
 4.3 Hospital-acquired ABSSSI
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Hospital-acquired ABSSSI: Geographic Segmentation Analysis
 4.4 Community-acquired ABSSSI
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Community-acquired ABSSSI: Geographic Segmentation Analysis

Chapter 5: Acute Bacterial Skin And Skin Structure Infections Market by Route of Administration
 5.1 Acute Bacterial Skin And Skin Structure Infections Market Snapshot and Growth Engine
 5.2 Acute Bacterial Skin And Skin Structure Infections Market Overview
 5.3 Oral
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Oral: Geographic Segmentation Analysis
 5.4 Parenteral
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Parenteral: Geographic Segmentation Analysis

Chapter 6: Acute Bacterial Skin And Skin Structure Infections Market by End User
 6.1 Acute Bacterial Skin And Skin Structure Infections Market Snapshot and Growth Engine
 6.2 Acute Bacterial Skin And Skin Structure Infections Market Overview
 6.3 Hospitals Pharmacy
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals Pharmacy: Geographic Segmentation Analysis
 6.4 Retail Pharmacy
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Retail Pharmacy: Geographic Segmentation Analysis
 6.5 Online Pharmacy
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Online Pharmacy: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Acute Bacterial Skin And Skin Structure Infections Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 ACHAOGEN INC (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ALLERGAN PLC (IRELAND)
 7.4 BASILEA PHARMACEUTICA LTD (SWITZERLAND)
 7.5 CUMBERLAND PHARMACEUTICALS INC (USA)
 7.6 GLAXOSMITHKLINE PLC (UK)
 7.7 MELINTA THERAPEUTICS (USA)
 7.8 MERCK & CO INC (USA)
 7.9 MYLAN NV (USA)
 7.10 PARATEK PHARMACEUTICALS INC (USA)
 7.11 PFIZER INC (USA)
 7.12 SANDOZ (SWITZERLAND)
 7.13 SHIONOGI & CO LTD (JAPAN)
 7.14 THE MEDICINES COMPANY (USA)
 7.15 THERAVANCE BIOPHARMA INC (USA)
 7.16 WOCKHARDT LTD (INDIA)
 7.17 OTHER KEY PLAYERS

Chapter 8: Global Acute Bacterial Skin And Skin Structure Infections Market By Region
 8.1 Overview
 8.2. North America Acute Bacterial Skin And Skin Structure Infections Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Hospital-acquired ABSSSI
  8.2.4.2 Community-acquired ABSSSI
  8.2.5 Historic and Forecasted Market Size By Route of Administration
  8.2.5.1 Oral
  8.2.5.2 Parenteral
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Hospitals Pharmacy
  8.2.6.2 Retail Pharmacy
  8.2.6.3 Online Pharmacy
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Hospital-acquired ABSSSI
  8.3.4.2 Community-acquired ABSSSI
  8.3.5 Historic and Forecasted Market Size By Route of Administration
  8.3.5.1 Oral
  8.3.5.2 Parenteral
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Hospitals Pharmacy
  8.3.6.2 Retail Pharmacy
  8.3.6.3 Online Pharmacy
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Acute Bacterial Skin And Skin Structure Infections Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Hospital-acquired ABSSSI
  8.4.4.2 Community-acquired ABSSSI
  8.4.5 Historic and Forecasted Market Size By Route of Administration
  8.4.5.1 Oral
  8.4.5.2 Parenteral
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Hospitals Pharmacy
  8.4.6.2 Retail Pharmacy
  8.4.6.3 Online Pharmacy
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Acute Bacterial Skin And Skin Structure Infections Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Hospital-acquired ABSSSI
  8.5.4.2 Community-acquired ABSSSI
  8.5.5 Historic and Forecasted Market Size By Route of Administration
  8.5.5.1 Oral
  8.5.5.2 Parenteral
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Hospitals Pharmacy
  8.5.6.2 Retail Pharmacy
  8.5.6.3 Online Pharmacy
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Hospital-acquired ABSSSI
  8.6.4.2 Community-acquired ABSSSI
  8.6.5 Historic and Forecasted Market Size By Route of Administration
  8.6.5.1 Oral
  8.6.5.2 Parenteral
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Hospitals Pharmacy
  8.6.6.2 Retail Pharmacy
  8.6.6.3 Online Pharmacy
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Acute Bacterial Skin And Skin Structure Infections Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Hospital-acquired ABSSSI
  8.7.4.2 Community-acquired ABSSSI
  8.7.5 Historic and Forecasted Market Size By Route of Administration
  8.7.5.1 Oral
  8.7.5.2 Parenteral
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Hospitals Pharmacy
  8.7.6.2 Retail Pharmacy
  8.7.6.3 Online Pharmacy
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research